|
Date |
Guest |
Title |
|
May 9, 2008 |
Patrick DeLuca, PhD
Department of Pharmaceutical Sciences, University of Kentucky,
Lexington, KY
|
Microparticulate Drug Delivery Systems for Parenteral Administration |
|
March 24, 2008 |
Victor C. Yang, PhD
Department of Pharmaceutical Sciences,
University of Michigan, Ann Arbor , MI |
Strategies for Delivery of ProteinTherapeutics |
|
March 3, 2008 |
Thomas S. Ingallinera, RPh, PhD
Pharmaceutical Consultant, Charleston, SC |
Modern Alchemy: Pharmaceutical Development
in the 21st Century
|
|
January 28, 2008 |
Silvia Catinella, PhD
Chiesi Farmaceutici, Parma, Italy |
LC/MS in Pharmaceutical R&D |
|
January 9, 2008 |
Julie Johnson, PharmD
Department of Pharmacy Practice, University
Florida, Gainesville, FL |
Pharmacogenetics of antihypertensive agents:
Blood pressure lowering and outcomes |
|
December 10, 2007 |
Scott E. Snyder, PhD
Division of Nuclear Medicine
St. Jude Children's Research
Hospital, Memphis, TN |
PET Radiopharmaceutical Research at St
Jude |
|
December 3, 2007 |
Athar
H.
Chishti, PhD
University
of Illinois at Chicago
|
Calpain-1: A critical regulator of
tyrosine phosphorylation and cell signaling |
|
September 17, 2007 |
Lawrence
L. Fleckenstein, PharmD
Dept
of Clinical & Administrative Pharmacy, University of Iowa, Iowa
City, IA
|
Preclinical
and Clinical Development of a New Antimalarial Combination
|
|
May
21, 2007 |
Jose
L. Lopez-Ribot, PharmD, PhD
Department
of Biology
University
of Texas, San Antonio, TX
|
Candida
albicans Biofilms
|
|
May
14, 2007 |
David
E. Smith, PhD
Department
of Pharmaceutical Sciences
University
of Michigan, Ann Arbor, MI
|
Role
of PEPT2 in 5-Aminolevulinic Acid Neuroprotection
|
|
April
16, 2007 |
Thomas
R. Webb, PhD
Department
of Chemical Biology and Therapeutics, St Jude Children's Research Hospital
|
Some
Applications of High Throughput Chemistry tot he Discovery of Early Drug
Leads
|
|
April
9, 2007 |
Courtney
Fletcher, PhamrD
Department
of Clinical Pharmacy
University
of Colorado, Denver, CO
|
Pharmacologic
Contribution to Therapeutic Success with Antiretroviral Agents
|
|
April
2, 2007 |
Alexandros
Makriyannis, PhD
Bouvé
College of Health Sciences
Northeastern
University, Boston, MA
|
The
Endocannabinoid System as a Therapeutic Target
|
|
February
12, 2007 |
Kim
Brouwer, PharmD, PhD
Division
of Pharmacotherapy and Experimental Therapeutics
University
of North Carolina, Chapel Hill, NC
|
Probing
Hepatobiliary Drug Clearance in Humans: Translating from Bench to Bedside
|
|
January
25, 2007 |
Alice
M. Clark
Department
of Pharmacognosy
University
of Mississippi, Oxford, MS
|
The
Evolution of Antifungal Drug Discovery
|
|
January
8, 2007 |
Sharyn
Baker, PharmD, PhD
Pharmaceutical
Sciences Department
St.
Jude Children's Research Hospital
|
Determinants
of Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
|
|
November
13, 2006 |
David
H. Feeny, PhD Kaiser
Permanente Center for Health Research, Portland,
OR
|
The
Multi-Attribute Utility Approach for Assessing Health-Related Quality of
Life
|
|
October
23, 2006 |
Marc
Gastonguay, PhD
Metrum
Research Group, Tariffville,
CT
|
Bayesian Concepts and Methods in
Pediatric Clinical Trials
|
|
October
16, 2006 |
Wei-Chiang
Shen, PhD
University
of Southern California
Los Angeles, CA
|
Transferrin Receptor-mediated Oral
Absorption of Protein and Peptide Drugs: From Chemical Conjugates to
Recombinant Fusion Proteins
|
|
October
2, 2006 |
Amita
Joshi, PhD
Genentech
Inc.
South San Francisco, CA
|
Integration
of Pharmacokinetics and Pharmacodynamics in the Development of Biologics
at Genentech: SomeExamples
|
|
September
11, 2006 |
Alex
Sparreboom, Ph.D.
Department
of Pharmaceutical Sciences
St.
Jude Children's
Research
Hospital
|
Paclitaxel
chemotherapy: from empiricism to a mechanism-based formulation strategy
|
|
May 15, 2006
|
R.
Kiplin Guy, Ph.D.
Chemical Biology & Therapeutics, St. Jude Children's Research Hospital,
Memphis, TN
|
Screening
and Synthesis for Novel Antimalarials
|
|
April 10, 2006 |
Christopher
M. Waters, Ph.D.
UTHSC
Dept of Physiology
|
Lung Injury and Repair:
Biomechanics and Wound Healing
|
|
March 23, 2006 |
Christopher
A. Lipinski, Ph.D.
Pfizer Global R&D, Groton, CT
|
Target Validation, Drug Discovery,
Chemistry Space and Biology-Chemistry Disconnects
|
|
January 23, 2006 |
Edwards
A. Park, Ph.D.
UTHSC
Dept of Pharmacology
|
Nuclear
receptors and the regulation of metabolic genes
|
|
November 21, 2005 |
Anisul
Quadir, Ph.D., R.Ph.
BASF
North America
|
Characterization of Newly Developed
Micronized Poloxamers for Poorly
Soluble Drugs
|
|
November 14, 2005 |
Alexander V. Kabanov, Ph.D.
Center
for Drug Delivery and Nanomedicine University of Nebraska, Omaha, NE
|
Advances in Polymer Therapeutics and Nanomedicine
|
|
September 26, 2005 |
ChiYuan
Wu, Ph.D.
Bristol-Myers
Squibb, Princeton, NJ |
When BCS and PK Collide: Implications
for Biopharmaceutical Science
|
|
September 19, 2005 |
Daniel
L. Baker, Ph.D.
UTHSC
Dept of Medicine - Vascular Biology
|
Characterization of protein targets of
lysophosphatidic acid
|
|
August 29, 2005 |
Lawrence
J. Lesko, Ph.D.
Center
for Drug Evaluation and Research
U.S.
Food & Drug Administration, Rockville, MD |
Pharmacogenomics: Facts Catching up to
the Hype
|
|
August 22, 2005 |
Matthias
Schwab, M.D.
Dr.
Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart,
Germany
|
Children
are not Small Adults: Rationale for Definition of Subpopulations
|
|
April 25, 2005 |
Abby
L. Parrill, Ph.D. University
of Memphis, Memphis, TN
|
Model-Driven Investigation of
Phospholipid Receptor Structural Biology
|
|
March 24, 2005 |
John
F. Carpenter, Ph.D.
University
of Colorado, Denver, CO
|
Protein Aggregation in Aqueous Solution Formulations: Pathways and Inhibition
|
|
February 28, 2005 |
Trevor
Sweatman, Ph.D. UTHSC
Dept of Pharmacology
|
Mitochondrial
PKC as a Developmental Drug Target: The Long and Winding Road
|
|
December
13, 2004 |
Jeffrey
Hughes, Ph.D.
University
of Florida, Gainesville,
FL
|
Gene
Delivery: A pharmaceutics perspective |
November
29, 2004 |
Jeffrey
S. Barrett, Ph.D.
University
of Pennsylvania, Philadelphia,
PA
|
Modeling
and simulation approaches in the guidance of pediatric dose selection
for the LMWH tinzaparin |
October
25, 2004 |
Allen
Hoffman, Ph.D.
University
of Washington, Seattle,
WA
|
Smart
Polymers for Drug and Gene Delivery |
|
October
11, 2004
|
Kenneth
D. Hinds, Ph.D
PR
Pharmaceuticals, Fort
Collins, CO
|
Bioconjugation
and PEGylation for Protein and Peptide Delivery
|
September
13, 2004 |
Seng
Cheng, Ph.D.
Genzyme
Corporation, Cambridge,
MA
|
Prospects
for AAV-Mediated Gene Therapy of Lysosomal Storage Disorders |
|
April
26, 2004
|
Donald
Bashford, Ph.D.
Molecular
Biotechnology
St.
Jude Children's Research Hospital, Memphis
TN
|
Continuum
Methods for Modeling Electrostatic Effects in Protein Structure and
Function
|
|
March
22, 2004
|
Walter
G. Chambliss, Ph.D.
National
Center for Natural Products Research, Department of Pharmaceutics
University
of Mississippi, Oxford MS
|
Controlled
Release Dietary Supplements:
Science
or Hype?
|
|
February
9, 2004 |
Ashim
K. Mitra, Ph.D.
Division
of Pharmaceutical Sciences
University
of Missouri, Kansas
City, MO
|
Identification of Transporters and
Efflux Proteins on the Cornea and their role in Ocular Drug Delivery |
|
January
23, 2004
|
Sung
Wan Kim, Ph.D.
Center
for Controlled Chemical Delivery
Department
of Pharmaceutics and Pharmaceutical Chemistry
University
of Utah, Salt Lake City, UT
|
Biofunctional
Polymers for Gene Delivery
Treatment
of Cancer and Cardiovascular Diseases
|
October
1, 2003 |
William
P. Purcell, Ph.D.
Molecular
Design International, Memphis TN
|
Strategies
in Drug Development
|
|
September
29, 2003
|
Guang
W. Lu, Ph.D.
Pfizer,
AAPS
Visiting Scientist
|
Tropical
and Transdermal Delivery of Therapeutic Agents |
|
September
22, 2003
|
Mary
Lynne Hedley, Ph.D.
Zycos,
Boston,
MA
|
Polymeric
DNA Delivery Systems:
A
Clinical Significance
|
|
August
25, 2003
|
Michael
Shapiro, Ph.D.
Lilly
Research Laboratories, Indianapolis
IN
|
Ligand Target Interactions by NMR
|
March
31, 2003 |
Linda
Harris, Ph.D.
Department
of Molecular Pharmacology
St.
Jude Children's Research Hospital
|
Functions
of MDM2 in Human Tumors
|
|
March
17, 2003
|
Richard
Darrington, Ph.D.
Pfizer,
Inc., Groton,
CT
|
Rapid and Accurate Prediction of
Degradant Formation Rates in Pharmaceutical Formulations using HPLC-MS |
|
February
24, 2003 |
Steve
Morris, Ph.D.
St.
Jude Children's Research Hospital
Memphis,
TN
|
Anaplastic
lymphoma kinase (ALK):
A
target for small molecule inhibitor-based therapy |
February
17, 2003 |
Antonio
M. Ferreira, Ph.D.
Computational
Research on Materials Institute
University
of Memphis, Memphis,
TN
|
Exploring
the Electronic Structure of Novel Classical Canabinoids |
|
January
27, 2003
|
Stephen
W. White, D. Phil.
Department
of Structural Biology
St.
Jude Children's Research Hospital, Memphis,
TN
|
Structural
Studies on Bacterial Fatty Acid Syntheses Enzymes and the Development of
Novel Antibiotics
|
|
November
25, 2002 |
Debra
Bautista, Ph.D.
Eastern
Kentucky University, Richmond,
KY
|
Computational
Studies of Several G Protein-Coupled Receptors: A Collection of
Undergraduate Projects |
|
October
21, 2002
|
Engin
H. Serpersu, Ph.D.
Director
COE Structural Biology
University
of Tennessee, Knoxville,
TN
|
Binding
of Aminoglycoside Antibiotics to Aminoglycoside-Resistance Enzymes
|
|
October
14, 2002
|
Pamela
Small, Ph.D.
Department
of Microbiology
University
of Tennessee, Knoxville,
TN
|
Macrolide-Mediated
Toxicity and Immunosuppression in Mycobacterium Ulcerans
|
|
October
7, 2002 |
Jogarao
V. Gobburu, Ph.D.
Center
for Drug Evaluation and Research
Food and Drug Administration,
Rockville,
MD
|
Prognostic
Factors: Assessment of Clinical Relevance |
|
September
23, 2002
|
Richard
Wunderink, M.D.
Methodist
University Hospital, Memphis,
TN
|
Genetics
of Acute Inflammatory Disease
|
|
May
20, 2002 |
Mary-Ann
Bjornsti, Ph.D.
Department
of Molecular Pharmacology
St.
Jude Children's Research Hospital, Memphis,
TN
|
Cellular
Responses to DNA Topoisomerase I Poisons
|
|
May
6, 2002
|
James
C. Bigelow, Ph.D.
Biomes
Pharmaceuticals, Rockford,
MI
|
The
Apicoplast: A New Target for Anti-Malarial Drug Development |
|
April
22, 2002
|
Mark
Kemper, Ph.D.
ThermoNicolet Corporation
|
The
Use of Vibrational Spectros Techniques to Analyze the Ketoprofen Content
in Topical Gel Formulations
|
|
April
18, 2002
|
Richard
T. Wheelhouse, Ph.D.
University
of Bradford, UK
|
Tailoring
Ligands for High-Order DNA Structure
|
|
April
8, 2002 |
Hamid
Rezaei, Ph.D.
AstraZeneca
Pharmaceuticals, Philadelphia,
PA
|
Effect
of Molecular Weight of Polyethylene Glycols on Their Function as
Lubricant Sparing Binders in Tablet Technology
|
|
April
1, 2002
|
Robert
C. Reynolds, Ph.D
Southern
Research Institute, Birmingham,
AL
|
The
Design and Preparation of New Antitubercular Agents |
|
March
4, 2002 |
Kristine
Radomski Crews, Pharm.D.
Department
of Pharmaceutical Sciences
St.
Jude Children's Research Hospital, Memphis,
TN
|
Pharmacogenetic
Determinants of Toxicity to the Topoisomerase I Poison Irinotecan |
|
February
25, 2002 |
David
W. Grainger, Ph.D.
Department
of Chemistry
Colorado
State University, Fort
Collins, CO
|
Protein
Delivery for Bone Neogenesis and Antimicrobial Properties in an
Implanted Biomaterials Context |
|
February
18, 2002 |
Brenda
A. Shulman, Ph.D.
Departments
of Stuctural Biology and Tumor Cell Biology
St.
Jude Children's Research Hospital, Memphis,
TN
|
Molecular
Recognition in Cell Cycle Control |
|
January
28, 2002
|
Mary
K. Danks, Ph.D.
Department
of Molecular Pharmacology
St.
Jude Children's Research Hospital, Memphis,
TN
|
Development
of Novel Approaches for the Treatment of Neuroblastoma
|
|
January
14, 2002 |
Eldon
E. Geisert, Jr., Ph.D.
Department
of Anatomy and Neurobiology
University
of Tennessee Health Science, Center, Memphis,
TN
|
Hypothesis
versus Data-Driven Research:
Which
is Better? |
|
November
28, 2001
|
Anisul
Quadir, Ph.D.
BASF
Corporation
|
Challenges
of Solubalizing Poorly Soluble Drugs
|
|
October
30, 2001
|
John
Cassidy, Ph.D.
Ohio
State University, Columbus, OH
|
Food,
Nutrition and the Chemoprevention of Cancer
|
|
October
26, 2001
|
Malcolm
Rowland, Ph.D.
University
of Manchester, Manchester,
United
Kingdom
|
Models,
Man and Modern Medicines:
The
Age of Prediction
|
|
August
30, 2001 |
Lloyd
Tillman, Ph.D.
Isis
Pharmaceuticals, Carlsbad,
CA
|
Oral
Delivery of Antisense Oligonucleotides |
|
April
30, 2001
|
Lawrence
Yu, Ph.D.
Center
for Drug Evaluation and Research
U.S.
Food & Drug Administration, Rockville, MD
|
e-ADME
in Drug Discovery, Development, and Regulatory
|
|
April
23, 2001 |
Peter
A. Crooks, Ph.D.
Department
of Pharmaceutical Sciences
University
of Kentucky, Lexington, KY
|
Development
of Neuronal Nicotinic Acetylcholine Receptor Ligands:
New
Opportunities in Drug Discovery
|
|
April
9, 2001
|
John
H. Rodman, Pharm.D.
Department
of Pharmaceutical Sciences
St.
Jude Children's Research Hospital, Memphis,
TN
|
Clinical
Pharmacology and Pediatric Drug Development:
Busulfan
as a Case Study |
|
February
26, 2001
|
Chris
Dealwis, Ph.D.
Department
of Biochemistry and Cellular Biology
University
of Tennessee, Knoxville,
TN
|
Structure-based
Drug Design:
The
Study from Renin to HIV
|
|
February
19, 2001
|
David
Rotella, Ph.D.
Bristol
Myers
Squibb Company
|
Discovery
and Optimization of PDE-5 Inhibitors
|
|
February
1, 2001 |
Wolfgang
Sadee, Ph.D.
University
of California, San
Francisco, CA
|
Using
Genetic and Genomic Information in Drug Discovery and Therapy
|
|
January
22, 2001
|
Michael
S. Wolfe, Ph.D.
Brigham
and Women's Hospital and Harvard Medical School, Boston,
MA
|
Unmasking
Alzheimer Secretases:
New
Features and Familiar Faces |
|
November 20, 2000 |
Clinton F. Stewart, Pharm.D.
Department
of Pharmaceutical Sciences
St.
Jude Children's Research Hospital, Memphis,
TN
|
application of Pharmacokinetic Studies
to Optimize Topoisomerase Inhibitor Dosing in Children with Cancer |
|
October
9, 2000 |
David
C. Baker, Ph.D.
Department
of Chemistry
University
of Tennessee, Knoxville,
TN
|
Approaches
to Cancer Chemotherapy:
1)
New Potent, Broad-Spectrum Antitumor Compounds and
2)
Antimetastatic Oligosaccharides from Hyaluronic Acid |
|
October 2, 2000 |
Bill J. Gurley, Ph.D.
University of Arkansas for Medical Sciences, Little Rock, AR
|
Herbal Dietary Supplements: A Pharmaceutical
Scientist's Perspective |
|
September
18, 2000 |
Charles
O. Rock, Ph.D.
Department
of Biochemistry
St.
Jude Children's Research Hospital, Memphis,
TN
|
Bacterial
Fatty Acid Synthesis as a Target for Drug Discovery |
|
September
11, 2000 |
Eugene
Y. Krynetski, Ph.D., D.Sci.
Department
of Pharmaceutical Sciences
St.
Jude Children's Research Hospital, Memphis,
TN
|
New
Targets in Thiopurine Antileukemic Therapy |
|
August 28, 2000
|
Richard
B. Kim, M.D.
Division
of Clinical Pharmacology
Vanderbilt
University, Nashville, TN
|
Drug
Transporters in Drug Disposition and Response |
